Certolizumab in Recurrent Implantation Failure (RIF)

Clinical trial NCT05930613 · RECRUITING

Trial details

NCT number: NCT05930613
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Unexplained Implantation Failure

Start date: 2023-11-30
Primary completion: 2029-04-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.